Using GLUT5-directing 2,5-anhydro-D-mannitol (mannitol), we have aimed to explore the feasibility of delivering a bioactive cargo through GLUT5 and achieving cancer specificity of the cytotoxic response. The gene discussed is SLC2A5; the disease is cancer.